| 1 |
18600568 | From the bench to the bedside: dipeptidyl peptidase IV inhibitors, a new class of oral antihyperglycemic agents. | 2008 Jul |
1 |
| 2 |
15522230 | NMR structure of the glucose-dependent insulinotropic polypeptide fragment, GIP(1-30)amide. | 2004 Dec 3 |
2 |
| 3 |
10102692 | NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. | 1999 Apr |
1 |
| 4 |
7556958 | Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. | 1995 Oct |
1 |
| 5 |
7589426 | Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma. | 1995 Oct 2 |
1 |
| 6 |
8100523 | Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. | 1993 Jun 15 |
1 |
| 7 |
18407095 | Insulinotropic glucagonlike peptide-I(7-37)/(7-36)amide A new incretin hormone. | 1992 Jul |
1 |
| 8 |
1767243 | Hyperglycaemia but not hyperinsulinaemia prevents the secretion of glucagon-like peptide-1 (7-36 amide) stimulated by fat ingestion. | 1991 Oct |
1 |